- BBS Pharmaceuticals Contact
- contact@bbspharmaceuticals.com
BBS Pharmaceuticals News
[display-posts include_excerpt=”true” excerpt_length=”20″ image_size=”thumbnail” wrapper=”div” wrapper_class=”display-posts-listing image-left”]
March 12, 2020
In the coming months, the TGA will expand the number of quality audits of medicinal cannabis products imported or supplied under the Special Access Scheme (SAS) […]
February 28, 2020
A scientific study conducted by Professor Poulas Konstantinos and his team from the Department of Pharmacy at the University of Patras in Greece, and in collaboration […]
February 20, 2020
Even on a good day, eight-year-old Sophie Martin has hundreds of seizures. When she has a severe seizure, she turns blue and cannot breathe. She has […]
February 14, 2020
Don’t bring others down! Message from BBS Pharmaceuticals’ CEO, John Dagas regarding the medicinal cannabis industry. “The start of 2020 has seen a number of medicinal […]
January 24, 2020
“Medicinal cannabis can be the healthcare success stotory of our lifetime,” says Hugh Hempel, In this moving talk, he discusses how medicinal cannabis has enriched the […]
January 17, 2020
“It’s the teams that make histotory… Alone, we can do so little; totogether we can do so much.” BBS was born one night as two friends, […]
January 17, 2020
BBS Pharmaceuticals featured in Health Europa Medical Cannabis Network’s latest issue…
December 3, 2019
The Food and Drug Administration (FDA) has approved a first-of-its-kind human trials study by the Yale School of Medicine in conjunction with CT Pharma that will […]
November 28, 2019
BBS’s Primary growth strategy is toto connect with the export markets. As a leader in the market of medicinal cannabis, BBS is focusing on establishing regional […]